A U.S. based drug development company consulted Freyr to complete review of ANDA against RTR (Refuse To Receive) standards and current USFDA (Food and Drug Administration) requirements within a short duration of time.
Read the case to see what were the different services and solutions Freyr offered to the client for the review process.
Fill the form below to download the Case Study
